Advertisement
Brief report| Volume 40, ISSUE 8, P804-806, October 15, 1996

Effect of the cholecystokinin-B receptor antagonist L-365,260 on lactate-induced panic attacks in panic disorder patients

DOI:https://doi.org/10.1016/0006-3223(96)00250-8
Effect of the cholecystokinin-B receptor antagonist L-365,260 on lactate-induced panic attacks in panic disorder patients
Previous ArticleChanges in the ratio of urinary α1-microglobulin to ulinastatin levels in patients with psychiatric diseases
Next ArticleThe effects of electroconvulsive shock on the thalamic auditory potential
      This paper is only available as a PDF. To read, Please Download here.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • American Psychiatric Association
        Diagnostic and Statistical Manual of Mental Disorders. 1987; (Washington, DC)
        • Bradwejn J
        • Koszycki D
        • Payena R
        • et al.
        Study of the replication of action of cholecystokinin in panic disorders.
        Am J Psychiatry. 1992; 149: 962-964
        • Bradwejn J
        • Koszycki D
        • Couëtoux du Tertre A
        • et al.
        The panicogenic effects of CCK-tetrapeptide are antagonized by L-365,260, a central CCK receptor antagonist in patients with panic disorder.
        Arch Gen Psychiatry. 1994; 51: 486-493
        • Coplan JD
        • Liebowitz MR
        • Gorman JM
        • et al.
        Noradrenergic function in panic disorder effects of intravenous clonidine pretreatment on lactate induced panic.
        Biol Psychiatry. 1992; 31: 135-146
        • Cowley DS
        • Dager SR
        • Roy-Byrne PP
        • Avery DH
        • Dunner DL
        Lactate vulnerability after alprazolan versus placebo treatment of panic disorder.
        Biol Psychiatry. 1991; 30: 49-56
        • den Boer JA
        • Westenberg HGM
        Behavioural biological and neuroendocrine concomitants of lactate-induced panic anxiety.
        Biol Psychiatry. 1989; 26: 612-622
        • Liebowitz MR
        • Fyer AJ
        • Gorman JM
        • et al.
        Lactate provocation of panic attacks: I. Clinical and behavioral findings.
        Arch Gen Psychiatry. 1984; 41: 764-770
        • Rifkin A
        • Klein DF
        • Dillon D
        Blockade by imipramine or desipramine of panic induced by sodium lactate.
        Am J Psychiatry. 1981; 138: 676-677
        • van Megen HJGM
        • den Boer JA
        • Westenberg HGM
        On the significance of cholecystokinin receptors in panic disorder.
        Prog Neuropsychopharmacol. 1994; 18: 1235-1246
        • Westenberg HGM
        • den Boer JA
        Neuropharmacology of anxiety.
        in: Handbook of Anxiety and Depression. Marcel Dekker, Washington DC1994: 405-447

      Article info

      Publication history

      Received in revised form: February 16, 1996
      Received: July 21, 1995

      Identification

      DOI: https://doi.org/10.1016/0006-3223(96)00250-8

      Copyright

      © 1996 Society of Biological Psychiatry. Published by Elsevier Inc.

      ScienceDirect

      Access this article on ScienceDirect

      The content on this site is intended for healthcare professionals.


      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties.


      RELX